In this T-cell-deficient model, tumor growth in IFITM3-overexpressing mice was comparable to that observed in the controls, indicating that the antitumor effects of IFITM3 overexpression are dependent on T-cell-mediated immunity (Fig. 4F). Here, IFITM3 is linked to neoplasm.